Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002535938 | SCV000962779 | pathogenic | Ocular cystinosis; Juvenile nephropathic cystinosis; Inborn genetic diseases | 2024-02-17 | criteria provided, single submitter | clinical testing | This sequence change affects an acceptor splice site in intron 9 of the CTNS gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in CTNS are known to be pathogenic (PMID: 9537412, 27102039). This variant is not present in population databases (gnomAD no frequency). Disruption of this splice site has been observed in individuals with cystinosis (PMID: 19863563, 27858370). ClinVar contains an entry for this variant (Variation ID: 664004). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV005092452 | SCV002783546 | likely pathogenic | Ocular cystinosis; Juvenile nephropathic cystinosis; Nephropathic cystinosis | 2021-11-11 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV003473516 | SCV004212947 | pathogenic | Nephropathic cystinosis | 2023-09-24 | criteria provided, single submitter | clinical testing | |
Gene |
RCV004702460 | SCV005201713 | pathogenic | not provided | 2023-11-08 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); Canonical splice site variant predicted to result in an in-frame loss of the adjacent exon in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 25525159, 19863563, 27858370) |